Dysmenorrhea Treatment Market 2017 - Current and Future Plans
SUMMARY
Market Synopsis of Middle East and Africa Dysmenorrhea Treatment Market: Global Forecast till 2023
Market Scenario:
Dysmenorrhea is a medical term for painful menstruation. Many women suffer from pain in lower abdomen during menstruation. This is due to low hemoglobin levels in women’s and lack of nutritious diet taken by women. Women nowadays have to cope up with both physical and mental stress due to personal issues and other work related problems. Most of them consult a physician for various reproductive disorders. The demand for the treatment of dysmenorrhea is increasing due to increasing reproductive disorders in women, irregular menstrual cycle, increase in lifestyle disorders and addiction to smoking deteriorating their physical and mental health. Lack of awareness about the treatment regarding various reproductive disorders and use of medications for their treatment also contribute for the growth of this market. Women in developed countries face many health issues due to lifestyle changes and many develop diseases related to reproductive health which favors the growth of this market in developed countries across the globe. Risk of developing serious disorders, if the disease remains untreated, would increase in demand of treatment in hospitals.Global market of Dysmenorrhea Treatment is expected to reach US$ 8.40 billion in 2023 from US$ 5.68 billion in 2016 with a CAGR of approximately 12.28% during the forecast period 2017-2023.
Regional Analysis of Dysmenorrhea Treatment Market:
Globally, Dysmenorrhea Treatment market is spread across four regions America, Europe, Asia-Pacific and Middle East and Africa. North America is the largest market for dysmenorrhea. The factor contributing for the growth of this market is an increase in problems with reproductive healthy among women and changing lifestyle. Asia Pacific is expected to be the fastest growing market for dysmenorrhea treatment. India is expected to be the emerging and fastest growing region. The market shows steady growth in Middle East and Africa.
Key Players for Dysmenorrhea Treatment Market:
Some of the key players in this market are: Novartis AG (Switzerland), Merck, Inc. (U.S), Bayer Schering Pharma AG (Germany), Abbott Healthcare(U.S), Pfizer, Inc.(U.S). Other players include F. Hoffmann-La Roche Ltd (U.S), Sanofi (U.S), Taj Pharmaceuticals, Ltd (India).
GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/727
Segmentation:
Global Dysmenorrhea Treatment market has been segmented on the basis of Type which includes Primary Dysmenorrhea and Secondary Dysmenorrhea. Secondary Dysmenorrhea has sub-segments namely Endometriosis, Adenomyosis, Uterine myomas, Endometrial polyps, Cervical stenosis, Obstructive malformations of genital tract. On the basis of treatment the market is segmented into non-steroidal anti-inflammatory drugs (NSAIDs), hormonal, and combined oral contraceptive. End users are hospitals and clinics, diagnostic centers, pharmaceutical companies and others.
The report for Dysmenorrhea Treatment market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions
Study Objectives:
Main objective of this research is to provide information about the products, their application and their end users
- To provide detailed analysis of the market structure along with forecast for the next six years of the various segments and sub-segments of the Dysmenorrhea Treatment market.
- To provide insights about factors affecting the market growth.
- To analyze the dysmenorrhea treatment market based on various factors- Price Analysis, Supply Chain Analysis, Porters Five Force Analysis etc.
- To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific and Middle East and Africa.
- To provide country level analysis of the market with respect to the current market size and future prospective.
- To provide country level analysis of the market for segments by type, by treatment, by end users and its sub-segments.
- To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
- To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Dysmenorrhea Treatment market.
Intended Audience
- Dysmenorrhea medicine suppliers
- Dysmenorrhea medicine manufacturers
- Research and Development (R&D) Companies
- Medical Research Laboratories
- Diagnostic centers
- Academic Medical Institutes and Universities
Table of Contents
- Report Prologue
- Market Introduction
- Research Methodology
- Market Dynamics
- Market Factor Analysis
- Global Dysmenorrhea Treatment market by type
- Global Dysmenorrhea Treatment market by treatment
- Global Dysmenorrhea Treatment market by end user
- Global Dysmenorrhea Treatment market by region
- Competitive Landscape
- Company Profile
- Conclusion
- Appendix
...CONTINUED
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
